![](https://investorshub.advfn.com/uicon/105308.png?cb=1488112867)
Friday, March 07, 2014 8:00:28 AM
I have had a few "BIRDY" reports that Wyeth was interested in FLUCIDE and now that GILEAD could be interested in HIVCIDE. Gilead states they have the most HIV medicines and they MIGHT NEED MORE. The NNVC non TOXIC and mild for children could be a real selling item.
If anything the SA article could have stirred up a lot of interest in NNVC in whole or in part. Anyone watching NNVC might have to step up plans.
It will be interesting who the stated suiter is in the SA story.
The last time anyone wanted to buy all of NNVC was the CHINESE and now they have more money and H7N to worry about.
The US needs to keep NNVC in the USA for manufacturing, employment and taxes with products going out all over the Earth and then money returning to the USA in higher amounts.
As for the stated price of up to 4.5 billion, that seemed a little low but Safeway just sold for 9.4 billion dollars and they have hundreds of stores or supermarkets. NNVC has the CIDES and the patents and IP values and should keep those for many decades and in the USA if possible.
It was nice to see someone else beside the posters and investors on this board thinks that NNVC is worth at least billions.
Echo20
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM